CBI provides integrated solutions to global health
CBI Activities
Collaboration

MIT CBI is home to the Biomanufacturing Consortium (BioMAN), and the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB). These pre-competitive programs provide a safe haven where industry, academia, and government collaboratively address challenges in manufacturing, delivery, and access to biologics through focused events and projects that address key challenges in biomanufacturing.
Education

MIT CBI has developed a number of biomanufacturing-related educational offerings including a residential MIT course, an on-line course on the principles of manufacturing protein and antibody drugs, and a short course on vaccine manufacturing offered jointly with University College London. We have developed a blended learning course for the training of cell therapy manufacturing personnel which will combine online learning with hands-on training.
Research

MIT CBI research projects focus on biomanufacturing process innovation for production of biologic medicines including monoclonal antibodies, vaccines, viral vectors, and cell therapies. Our main research areas include process analytical technologies, biomanufacturing data analytics, advanced process modeling and control, and continuous manufacturing.
Upcoming Events
2025 Vaccines Bioprocess Development & Commercialization Workshop
100 Main St, Building E62-250, Cambridge, MA, 100 Main St, Building E62-250, Cambridge, MA 02139
2025 BioMAN Workshop
Samberg Conference Center, 50 Memorial Drive, Cambridge MA
Latest News & Research
-
SMART Researchers Develop Rapid Detection Method for Microbial Contamination
Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) interdisciplinary research group of the Singapore-MIT Alliance for Research and Technology (SMART), MIT’s…
-
RFP 2024 Announced
MIT Center for Biomedical Innovation and the Coca-Cola Company announced the next request for proposals (RFP) with an application deadline of May…
-
FDA funds Center for Continuous mRNA Manufacturing
Researchers from MIT have received an award of $82 million over 3 years from the Food & Drug Administration…
Our Members
Our members and collaborators are leading stakeholders across the global healthcare value chain, from R&D and manufacturing to delivery and reimbursement.